Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Privia Health Group (PRVA)

Privia Health Q4 revenue up 17.4% to $541.2 million; 2026 outlook given

Positive Impact 3 of 5 earnings Written later

Privia Health reported fourth-quarter and full-year 2025 results, with Q4 revenue of $541.2 million, up 17.4% from a year earlier, and full-year revenue of $2.12 billion, up 22.3%. The company also issued 2026 guidance calling for GAAP revenue of $2.35 billion to $2.45 billion and Adjusted EBITDA of $145 million to $155 million, compared with $125.5 million in 2025.

Key points

  • Q4 2025 net income attributable to Privia was $9.2 million, versus $4.4 million in Q4 2024; full-year net income was $22.9 million, up 59.3%.
  • Full-year 2025 Adjusted EBITDA was $125.5 million, up 38.8%, and operating cash flow was $163.4 million, up 49.5%.
  • Year-end 2025 cash was $479.7 million with no debt.
  • 2026 guidance: GAAP revenue $2,350 million to $2,450 million; Adjusted EBITDA $145 million to $155 million; about $600 million expected year-end cash.

The filing

CompanyPrivia Health Group (PRVA)
Form8-K, current report
Filed with the SECFeb 26, 2026, 6:05 AM ET
Accession number0001759655-26-000007

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:49 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 26, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.